Incentives only work if people understand them and the paperwork survives diligence. We design schemes and tidy transactions so growth doesn’t slow to argue about equity.
Fees that won’t drift
Every mandate runs on a fixed fee – either a published package or a bespoke scope tuned to your team and timing.
If you only need one element (say, option agreements or an articles tweak), we’ll price that alone and lock it. If the brief changes, we re-scope first. No creep. No meter.
How we deliver scale work
Assess & model. We review cap-table shape, leaver history and hiring plans; you get a short note on risks and options.
Design. We pick the right route – EMI, CSOP, unapproved options, or growth shares—and set the parameters.
Draft & approve. Scheme rules, agreements and article changes prepared; board/shareholder approvals lined up.
Grant/issue. Grants or issuances completed, registers updated, notifications filed.
Aftercare. Plain-English admin notes so awards don’t get lost; we’re here when you add employees or adjust terms.
What working with us feels like
You’ll get straight answers on what fits your stage and why. If EMI is right, we make it work without turning it into a science project: sensible eligibility checks, a valuation that stands up, documents people can actually sign, and an HMRC notification that lands on time.
If CSOP or unapproved options make more sense, we say so and design accordingly. Where equity today should be equity tomorrow, we flag it. Where cash beats complexity, we say that too.
For growth shares, we keep the hurdle simple and the articles readable. Boards hate surprises, so we surface them early—especially around leavers, malus and good-/bad-leaver outcomes. On buy-backs and transfers, we choreograph the approvals, signature order and filings so nothing lingers.
Communication stays light: short emails, clear asks, quick calls when that’s faster. The work product is tidy and built to survive diligence. Your team understands what they’ve been granted.
Your investors can follow the maths without a decoder ring. That’s the aim: retain people, keep momentum, and have a cap table you’re happy to show.
EMI vs growth shares—how do we choose?
If you want broad grants with tax efficiency and future flexibility, EMI usually wins. If you need equity now and can adjust articles, growth shares can be cleaner. We’ll map your team and timeline, then recommend.
Can we “backdate” an EMI grant?
No. We can align grant timing to a defensible valuation window and prepare everything so approval and issue happen cleanly.
Do buy-backs need shareholder approval?
Yes. We’ll draft the contract and resolutions, run the completion, and handle filings and register updates so it closes correctly.
